secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGILENT TECHNOLOGIES, INC. (A)
CIK:        0001090872
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0001090872-25-000010
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agilent reorganizes segments into Life Sciences & Diagnostics Markets, Agilent CrossLab, Applied Markets
--------------------------------------------------------------------------------

- Former Diagnostics & Genomics merged with LC/MS platforms into Life Sciences and Diagnostics Markets segment.
- Chemistries, supplies, lab automation, software, informatics moved to Agilent CrossLab segment.
- GC/MS, spectroscopy, vacuum divisions form new Applied Markets segment.
- Recast of 2024 10-K Items 1, 2, 7, 8 reflects new segments; no change to audited financials.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1090872/000109087225000010/0001090872-25-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1090872/000109087225000010/a-20250303_d2.htm
  HTML page:      https://secwatch.observer/filing/0001090872-25-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer